AIMS: To analyse the extent, relationship and clinical significance of apoptosis and cell proliferation in synovial sarcoma. METHODS: Apoptosis was detected by TUNEL, and expression of Ki-67, Bcl-2, Bax and p53 was examined immunohistochemically in 72 synovial sarcomas. Their relation and correlation with clinicopathological parameters and survival rate were analysed. RESULTS: The average values of apoptosis index (AI) and Ki-67 labelling index (LI) were 0.76% and 28.30%, respectively. Both AI and Ki-67 LI in large-volume, high-grade and advanced-stage synovial sarcomas were significantly higher than those in small-volume, low-grade and early-stage ones (P<0.05 for all). And there was a linear relationship between AI and Ki-67 LI (r=0.751, P<0.001). All examined synovial sarcomas were positive for Bcl-2 and Bax, and only 20.8% cases showed expression of p53 protein. The expressions of Bcl-2, Bax and p53 were also significantly correlated with AI (P=0.005, P=0.002, P=0.037, respectively). In addition, patients with high AI (>0.76%) had poor prognosis (log-rank test; P=0.007). CONCLUSIONS: Alterations in apoptosis and cell proliferation activity might be responsible for the pathogenesis and behaviour of synovial sarcoma. Increased rate of apoptosis in synovial sarcoma was considered to be an indicator of poor prognosis. In addition, apoptosis in synovial sarcoma may be controlled by multiple apoptosis-regulating mechanisms, including the Bcl-2 family and p53 protein.
AIMS: To analyse the extent, relationship and clinical significance of apoptosis and cell proliferation in synovial sarcoma. METHODS: Apoptosis was detected by TUNEL, and expression of Ki-67, Bcl-2, Bax and p53 was examined immunohistochemically in 72 synovial sarcomas. Their relation and correlation with clinicopathological parameters and survival rate were analysed. RESULTS: The average values of apoptosis index (AI) and Ki-67 labelling index (LI) were 0.76% and 28.30%, respectively. Both AI and Ki-67 LI in large-volume, high-grade and advanced-stage synovial sarcomas were significantly higher than those in small-volume, low-grade and early-stage ones (P<0.05 for all). And there was a linear relationship between AI and Ki-67 LI (r=0.751, P<0.001). All examined synovial sarcomas were positive for Bcl-2 and Bax, and only 20.8% cases showed expression of p53 protein. The expressions of Bcl-2, Bax and p53 were also significantly correlated with AI (P=0.005, P=0.002, P=0.037, respectively). In addition, patients with high AI (>0.76%) had poor prognosis (log-rank test; P=0.007). CONCLUSIONS: Alterations in apoptosis and cell proliferation activity might be responsible for the pathogenesis and behaviour of synovial sarcoma. Increased rate of apoptosis in synovial sarcoma was considered to be an indicator of poor prognosis. In addition, apoptosis in synovial sarcoma may be controlled by multiple apoptosis-regulating mechanisms, including the Bcl-2 family and p53 protein.
Authors: Anna Fishbein; Weicang Wang; Haixia Yang; Jun Yang; Victoria M Hallisey; Jianjun Deng; Sanne M L Verheul; Sung Hee Hwang; Allison Gartung; Yuxin Wang; Diane R Bielenberg; Sui Huang; Mark W Kieran; Bruce D Hammock; Dipak Panigrahy Journal: Proc Natl Acad Sci U S A Date: 2020-08-14 Impact factor: 11.205
Authors: K B Jones; L Su; H Jin; C Lenz; R L Randall; T M Underhill; T O Nielsen; S Sharma; M R Capecchi Journal: Oncogene Date: 2012-07-16 Impact factor: 9.867
Authors: Catriona A Ford; Sofia Petrova; John D Pound; Jorine J L P Voss; Lynsey Melville; Margaret Paterson; Sarah L Farnworth; Awen M Gallimore; Simone Cuff; Helen Wheadon; Edwina Dobbin; Carol Anne Ogden; Ingrid E Dumitriu; Donald R Dunbar; Paul G Murray; Dominik Ruckerl; Judith E Allen; David A Hume; Nico van Rooijen; John R Goodlad; Tom C Freeman; Christopher D Gregory Journal: Curr Biol Date: 2015-02-19 Impact factor: 10.834
Authors: Megan L Sulciner; Charles N Serhan; Molly M Gilligan; Dayna K Mudge; Jaimie Chang; Allison Gartung; Kristen A Lehner; Diane R Bielenberg; Birgitta Schmidt; Jesmond Dalli; Emily R Greene; Yael Gus-Brautbar; Julia Piwowarski; Tadanori Mammoto; David Zurakowski; Mauro Perretti; Vikas P Sukhatme; Arja Kaipainen; Mark W Kieran; Sui Huang; Dipak Panigrahy Journal: J Exp Med Date: 2017-11-30 Impact factor: 14.307